Global AI-based Clinical Trials Solution Provider Market Research Report (2021 to 2027) – by Phase, Application, End-user and Region | News

DublinAnd Jan 31 2022 /PRNewswire/ – “AI-Based Clinical Trial Solution Provider Research Report by Phase, by Application, by End User, by Region – Global Forecast to 2027 – COVID-19 Cumulative Impact Report” has been added to Show.

Global Artificial Intelligence-Based Clinical Trial Solution Provider Market Size Estimated 4,499.63 Million USD In 2020, it is expected to reach 4,938.35 Million USD In 2021, it is expected to grow at a compound annual growth rate of 10.11%. 8,833.41 million USD by 2027.

Market Statistics:

The report presents the market size and forecast across five major currencies – the US dollar, the euro, the British pound, the Japanese yen and the Australian dollar. It helps organizations leaders make better decisions when currency exchange data is readily available. In this report, 2018 and 2019 are historical years, 2020 is a base year, 2021 is an estimated year, and the years 2022 to 2027 are the forecast period.

Competitive strategic window:

The Competitive Strategy Window analyzes the competitive landscape in terms of markets, applications, and geographies to help the seller determine the fit or suitability of its capabilities and opportunities for future growth prospects. Describes the optimal or favorable suitability for vendors to adopt successive merger and acquisition strategies, geographic expansion, research and development, and new product introduction strategies to carry out further expansion and growth of the business over a forecast period.

FPNV Matrix Positioning:

FPNV Matrix positions and rates the vendors in the AI-based clinical trial solutions provider market based on business strategy (business growth, industry coverage, financial viability, channel support) and product satisfaction (value for money, ease of use, product features, customer support ) that helps companies make better decisions and understand the competitive landscape.

Market share analysis:

Market share analysis provides an analysis of the vendors given their contribution to the market as a whole. It provides the idea of ​​revenue generation in the market as a whole as compared to other suppliers in the space. It provides insight into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing the market share provides an idea of ​​the size and competitiveness of the vendors for the base year. It reveals the characteristics of the market in terms of accumulation, fragmentation, domination, and merger.

Company Usability Profiles:

The report explores in depth the recent significant developments by the leading vendors and innovation profiles in the global AI-based clinical trial solutions provider market, including AiCure, LLC, Aiforia, Antidote Technologies, Inc., Avantor, Inc., Deep 6 AI, Deep Lens Inc. and Innoplexus Consulting Services Pvt Ltd,, MEDIAN Technologies,, Pharmaceutical Pipeline Enhancement Strategies, LLC, Saama Technologies Pvt Ltd, Simplifai AS,, Unlearn.AI, Inc..

The report provides insights into the following indicators:

1. Market Penetration: Provides comprehensive market information provided by the major players

2. Market Development: Provides in-depth information on profitable emerging markets and penetration analysis across mature market segments

3. Market diversification: Provides detailed information on new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment and Intelligence: Provides a comprehensive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of the leading players

5. Product development and innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and outlook for the global Artificial Intelligence-Based Clinical Trial Solution Provider market?

2. What are the dampening factors and impact of COVID-19 in shaping the global Artificial Intelligence-Based Clinical Trial Solution Providers market during the forecast period?

3. Which products/segments/applications/areas to invest in during the forecast period in the global AI-based clinical trial solutions provider market?

4. What is the competitive strategic window of opportunity in the global AI-based clinical trial solutions provider market?

5. What are the technology trends and regulatory frameworks in the global Artificial Intelligence-Based Clinical Trial Solution Provider Market?

6. What is the market share of the leading vendors in the global Artificial Intelligence-Based Clinical Trial Solution Provider market?

7. What patterns and strategic moves are suitable for entering the global AI-based clinical trial solutions provider market?

Main topics covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market insights

5.1 Market dynamics

5.1.1. drivers The need for artificial intelligence that helps enhance and improve clinical trials Increased needs to reduce healthcare costs and lower device costs Increasing adoption of AI-based drug development technology by most pharmaceutical companies

5.1.2. limitations Lack of personal participation leads to high unemployment rates Possible misdiagnosis

5.1.3. chances Technological advances and innovations in AI-based clinical trials Big pharma ensures more joint ventures and partnerships with AI vendors

5.1.4. Challenges Concerns associated with the adoption of electronic health records interoperability

5.2 Cumulative Impact of COVID-19

6. Artificial Intelligence Based Clinical Trials Solutions Market, by Stage

6.1 Introduction

6.2 First stage

6.3 Phase Two

6.4 Third stage

7. Artificial Intelligence Based Clinical Trials Solutions Market, by Application

7.1 Introduction

7.2 Cardiovascular disease

7.3. Infectious diseases

7.4. metabolic diseases

7.5 Neurological diseases or conditions

7.6 Oncology

8. AI-Based Clinical Trial Solution Provider Market, by End User

8.1 Introduction

8.2 Academia

8.3 Aharon

8.4 Pharmaceutical companies

9. Americas AI-Based Clinical Trial Solution Provider Market

9.1 Introduction

9.2. Argentina

9.3 Brazil

9.4 Canada

9.5 Mexico

9.6 United States of America

10. Asia Pacific AI-Based Clinical Trial Solution Provider Market

10.1. an introduction

10.2. Australia

10.3. China

10.4. India

10.5. Indonesia

10.6. Japan

10.7. Malaysia

10.8. philippines

10.9. Singapore

10.10. South Korea

10.11. Taiwan

10.12. Thailand

11. EuropeAnd Middle east & Africa AI-Based Clinical Trials Solution Provider Market

11.1. an introduction

11.2. France

11.3. Germany

11.4. Italia

11.5. Holland

11.6. Qatar

11.7. Russia

11.8 Kingdom Saudi Arabia

11.9 South Africa

11.10. Spain

11.11. The United Arab Emirates

11.12. United kingdom

12. Competitive landscape

12.1. FPNV Matrix Positioning

12.1.1. Quarters

12.1.2. business strategy

12.1.3. product satisfaction

12.2. Market Ranking Analysis

12.3. Market share analysis, by major player

12.4. Competitive Scenario

12.4.1. gain integration

12.4.2. Agreement, Cooperation and Partnership

12.4.3. New product launch and improvement

12.4.4. investment and financing

12.4.5. Award, recognition and expansion

13. Company Usability Profiles

13.1. AiCure, y

13.2. Euphoria

13.3. Antidote Technologies, Inc.

13.4. Avantur, Inc.

13.5. Deep 6 AI

13.6. Deep Lens Inc.

13.7 Innoplexus Consulting Services Pvt Ltd

13.8 Intelligence

13.9 Media Technologies

13.10. Mendel

13.11. Pharmaceutical Pipeline Enhancement Strategies, LLC

13.12. Saama Technologies Pvt Ltd

13.13. Simplifai AS


13.15. Unlearn.AI, Inc.

14. Appendix

For more information on this report, visit

Media contact:

Research and Markets

Laura Wood, director, mentor

[email protected]

For EST office hours, call +1-917-300-0470

For the US/Canada, call toll free +1-800-526-8630

For GMT office hours, call +353-1-416-8900

US Fax: 607-646-1907

Fax (outside the US): +353-1-481-1716

Cision View original content:–to-2027—by-phase -Application-end-user-and-region-301471761.html

SOURCE Research & Markets

Leave a Comment